On The Pen: The Weekly Dose

Send us a Text Message.Dave Knapp does a deep dive into todays  Eli Lilly earnings call.https://www.onthepen.com/post/zepbound-vial-watch-eli-lilly-earnings-q1-2024MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinVenmo: OnThePenCa$h App: ManOnMounjaroSOCIAL LINKShttps://www.tiktok.com/@manonthemounjarohttps://twitter.com/ManOnMounjarohttps://instagram.com/manonthemounjarohttps://facebook.com/manonthemounjaroSupport the Show.Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message.1.7 mg of Wegovy is no longer in shortage:Semaglutide: FDA website updated to show 1.7 mg of Wegovy is no longer in shortageLink: https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Semaglutide%20Injection&st=cGNC introduces special section for GLP-1 users:GNC will have special section for GLP-1 users that will concentrate on four areas: GI Health, Retaining Lean muscle mass, Bone health, Nutritional supportLink: https://www.gnc.com/learn/newsroom/gnc-semaglutide-support-program.htmlIdentified upper dose values in tirzepatide high-dose trial20 mg and 25 mgPrimary Completion in this trial is 12/24/2024 (Merry Christmas) with final completion September 30, 2025 Link:  https://www.onthepen.com/post/higher-doses-of-zepbound-and-mounjaro-being-testedUS Senator Bernie Sanders investigating the price of Wegovy/OzempicOzempic costs $936 per month, while Wegovy costs $1,350Ozempic costs $155 in Canada, and cost $59 in Germany. This dramatic difference in cost has led to concerns about the accessibility and affordability of these drugs for American patients.With the cardiovascular disease indication, millions of additional medicare patients are eligible for taking Wegovy which means billions at the current prices Link:  https://www.onthepen.com/post/the-price-of-health-bernie-sanders-investigates-ozempic-and-wegovyLink: https://www.kff.org/medicare/issue-brief/a-new-use-for-wegovy-opens-the-door-to-medicare-coverage-for-millions-of-people-with-obesity/Germany is promoting their pharmaceuticals industry: tax breaks, and speeding up clinical trialsEli Lilly is investing 2.3 Billion Euros to build a glp-1 manufacturing plant in Germany:Link: https://uk.finance.yahoo.com/news/scholz-promises-support-pharma-sector-101833297.htmlLexaria begins phase 1 trial:Lexaria (stock symbol: LEXX) will test their technology to improve stomach absorption of Rybelsus in phase 1 trial (i.e. wouldn't need large 25/50 mg doses if absorption was better). They are also testing under tongue (sublingual) absorption of Rybelsus in another phase 1 trialLink: https://ir.lexariabioscience.com/news-events/press-releases/detail/246/lexaria-receives-ethics-review-board-approval-to-begin-newViking Therapeutics earnings callPlanning to start addition phase 2 trial of injectable VikingTide (VK2735) in Q4 of 2024 that will last 6-9 months (If you remember, the first phase 2 trial was only 13 weeks)The oral VikingTide (VK2735) phase 1 trial is still investigating higher and higher  doses due to the low side effect profile. They expect results in summer of 2024.MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinVenmo: OnThePenCa$h App: ManOnMounjaroSOCIAL LINKShttps://www.tiktok.com/@manonthemounjarohttps://twitter.com/ManOnMounjarohttps://instagram.com/manonthemounjarohttps://facebook.com/manonthemounjaroThank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message.New obesity medicine company launches, Lilly expands manufacturing capacity with acquisition, and TikTok censors my content.Email Alerts: https://www.onthepen.com/emailsBECOME A MEMBER HERE TO WATCH THE VIDEO:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinNew Obesity Medicine Company Launches: https://metsera.com/newsLilly Acquires Nexus Facility: https://finance.yahoo.com/news/lilly-buy-injectable-drug-plant-175000782.htmlTikTok Mounjaro Zepbound Censorship: https://www.bloomberg.com/news/articles/2024-04-22/tiktok-ozempic-influencers-say-new-rules-unfairly-target-themSOCIAL LINKShttps://www.tiktok.com/@manonthemounjarohttps://twitter.com/ManOnMounjarohttps://instagram.com/manonthemounjarohttps://facebook.com/manonthemounjaroThank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message.Dave Knapp makes the business case for why Eli Lilly won’t simply release the vials - they have to.Email Alerts: https://www.onthepen.com/emailsBECOME A MEMBER HERE TO WATCH THE VIDEO:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinBloomberg #ReleaseTheVials Feature:https://www.bloomberg.com/news/articles/2024-04-02/zepbound-shortage-patients-push-eli-lilly-to-release-more-obesity-drug-supplyYahoo Finanace #ReleaseTheVials Feature VIDEO: https://youtu.be/nQbYa47DF4Q?feature=shared#mounjaro #zepbound #tirzepatideThank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message.This week Dave Knapp covers GLP-1 censorship on TikTok,  the rise of bootleg medication scrutiny, and just how big the GLP-1 market may get in 2024.Email Alerts: https://www.onthepen.com/emailsBECOME A MEMBER HERE TO WATCH THE VIDEO:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinBloomberg #ReleaseTheVials Feature:https://www.bloomberg.com/news/articles/2024-04-02/zepbound-shortage-patients-push-eli-lilly-to-release-more-obesity-drug-supplyYahoo Finanace #ReleaseTheVials Feature VIDEO: https://youtu.be/nQbYa47DF4Q?feature=shared#mounjaro #zepbound #tirzepatideBootleg Meds:https://www.reuters.com/business/healthcare-pharmaceuticals/more-than-250-websites-selling-fake-weight-loss-drugs-reported-by-anti-2024-04-15/ Drug Shortage Reporting: https://www.wsj.com/health/healthcare/drug-medication-shortages-us-olympic-amoxicillin-107fa9d8GLP-1 Sales:https://www.fiercepharma.com/marketing/glp-1s-track-take-drug-sales-crown-pd-1-inhibitors-2024-analystThank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message.503a vs 503b pharmacies. What is the difference, and why you should care when it comes to compound tirzepatide and semaglutide.BECOME A MEMBER HERE TO WATCH THE VIDEO:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinGet the whole story at: https://www.onthepen.comBloomberg #ReleaseTheVials Feature:https://www.bloomberg.com/news/articles/2024-04-02/zepbound-shortage-patients-push-eli-lilly-to-release-more-obesity-drug-supplyYahoo Finanace #ReleaseTheVials Feature VIDEO: https://youtu.be/nQbYa47DF4Q?feature=shared#mounjaro #zepbound #tirzepatideThank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message.Get the whole story at: https://www.onthepen.comBloomberg #ReleaseTheVials Feature:https://www.bloomberg.com/news/articles/2024-04-02/zepbound-shortage-patients-push-eli-lilly-to-release-more-obesity-drug-supplyYahoo Finanace #ReleaseTheVials Feature VIDEO: https://youtu.be/nQbYa47DF4Q?feature=sharedYahoo Finance Catalent / Novo Deal Resubmission: https://finance.yahoo.com/news/novo-nordisk-parent-refiles-us-103118874.htmlBloomberg Lilly Germany Plant:https://www.bloomberg.com/news/articles/2024-04-08/lilly-s-2-5-billion-german-plant-will-boost-obesity-drug-supplyThank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message.In the largest move since approving Tirzepatide for chronic weight management in November of 2023, the FDA has posted the approval of a single-dose vial presentation of Zepbound. With the complexity of manufacturing the current single-dose pens, single dose vial presentations could prove to be an answer to increasing manufacturing shortages of Tirzepatide for both type 2 diabetes (Mounjaro) and chronic weight management (Zepbound). The FDA approved the single-dose vials of Mounjaro in July of 2023, but Eli Lilly has elected to offer that presentation in x-US markets only. https://www.onthepen.com/post/zepbound-single-dose-vials-approved-by-fda📲 Media Inquiries MounjaroMan@gmail.comAmazon Shop:https://www.amazon.com/shop/manonthemounjaroonthepen📼 PLAYLISTS:🖊️ ON THE PEN LIVES:https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM👀 WATCH MY MOUNJARO JOURNEY IN ORDER:https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW🚨📰 ALL THE LATEST MOUNJARO NEWS:https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yBThank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message.All things VikingTide from Viking Therapeutics VK2735https://ir.vikingtherapeutics.com/2024-03-26-Viking-Therapeutics-Announces-Results-from-Phase-1-Clinical-Trial-of-Oral-Tablet-Formulation-of-Dual-GLP-1-GIP-Receptor-Agonist-VK2735Amazon Remedies (affiliate links pay a commission that supports the channel):Alcohol Wipes: https://amzn.to/49WH0KrGinger Chews: https://amzn.to/43l6crATums: https://amzn.to/3vlzo59Peppermint Tea: https://amzn.to/3VjxT20👀 Find me everywhere + more community at: https://www.onthepen.com🥳 Support My Work! Become a member 🙂:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join📲 Media Inquiries MounjaroMan@gmail.com👩 Women's Hair loss Product: https://amzn.to/3qrl3lr👉 Link to other GLP-1 MUST HAVE products I mention:https://www.amazon.com/shop/manonthemounjaroonthepen📼 PLAYLISTS:🖊️ ON THE PEN LIVES:https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM👀 WATCH MY MOUNJARO JOURNEY IN ORDER:https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW🚨📰 ALL THE LATEST MOUNJARO NEWS:https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yBThank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message.Amazon Remedies (affiliate links pay a commission that supports the channel):Alcohol Wipes: https://amzn.to/49WH0KrGinger Chews: https://amzn.to/43l6crATums: https://amzn.to/3vlzo59Peppermint Tea: https://amzn.to/3VjxT20👀 Find me everywhere + more community at: https://www.onthepen.com🥳 Support My Work! Become a member 🙂:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join📲 Media Inquiries MounjaroMan@gmail.com👩 Women's Hair loss Product: https://amzn.to/3qrl3lr👉 Link to other GLP-1 MUST HAVE products I mention:https://www.amazon.com/shop/manonthemounjaroonthepen📼 PLAYLISTS:🖊️ ON THE PEN LIVES:https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM👀 WATCH MY MOUNJARO JOURNEY IN ORDER:https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW🚨📰 ALL THE LATEST MOUNJARO NEWS:https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yBThank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message.Big news from Novo Nordisk and we have it all for you!! Cagrisema, high dose Semaglutide, new Amycretin, a triple angonist and more!🎙️Weekly Podcast: https://podcasts.apple.com/us/podcast/on-the-pen-the-weekly-dose/id1725737068Best away To Support Me, Become a member 🙂:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join👉 My Amazon Storefront:https://www.amazon.com/shop/manonthemounjaroonthepen📲 Contact Me: MounjaroMan@gmail.com📼 PLAYLISTS:🖊️ ON THE PEN LIVES:https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW🚨📰 ALL THE LATEST MOUNJARO NEWS:https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB👀 WATCH MY MOUNJARO JOURNEY IN ORDER:https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiOThank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message.This week Dave covers the latest in the Change Healthcare Hack, some interesting pubmed tirzepatide  data , and Oprah’s exit from the Weight Watchers board of directors.Become a YouTube Community Member By Clicking Here:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinOn The Pen Live Show (All Episodes In Order): https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfMFor Those Facing GLP-1 Access Issues: Https://www.FlexFinance.CareTell them “Dave sent you” 😉Zepbound FB Group:https://www.facebook.com/share/oxMJXxuLTwczPpWq/?mibextid=K35XfPSHOW LINKSChange Healthcare Ransom Paid:https://www.wired.com/story/alphv-change-healthcare-ransomware-payment/Pubmed Asians vs. Non-Asians With DM2 Using Tirzepatidehttps://pubmed.ncbi.nlm.nih.gov/38402331/Oprah Leaving WW Boardhttps://www.thedailybeast.com/oprah-is-leaving-weightwatchers-after-revealing-weight-loss-drug-useDr. Michael Albert Interview:https://youtu.be/nB9CXEsGNDcThe Big Shot Reviewhttps://youtu.be/l-uyFOxqSYkThank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message.Dave Knapp (@ManOnTheMounjaro) joins Dr. Michael Albert, a leading voice in the obesity medicine, for a gripping conversation on the current and future state of obesity medicine.Become a Community Member By Clicking Here:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinOn The Pen Live Show (All Episodes In Order): https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfMFor Those Facing GLP-1 Access Issues: Https://www.FlexFinance.CareTell them “Dave sent you” 😉Zepbound FB Group:https://www.facebook.com/share/oxMJXxuLTwczPpWq/?mibextid=K35XfPThank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message.This week we cover:- New readouts on the new Boehringer Ingleheim investigational med Survodutide. - Wegovy launches in Japan, and the - Change Healthcare cyber attack and how it’s effecting your prescription refillsBecome a Community Member By Clicking Here:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinOn The Pen Live Show (All Episodes In Order): https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfMFor Those Facing GLP-1 Access Issues: Https://www.FlexFinance.CareTell them “Dave sent you” 😉Zepbound FB Group:https://www.facebook.com/share/oxMJXxuLTwczPpWq/?mibextid=K35XfPSHOW LINKSSurvodutide Top Line Data: https://www.biospace.com/article/boehringer-s-obesity-candidate-shows-strong-potential-in-mash/Wegovy in Japan: https://www3.nhk.or.jp/nhkworld/en/news/20240222_34/Change Healthcare Hack: https://www.fastcompany.com/91037949/change-healthcare-cyber-attack-update-pharmacies-big-dealThank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message.Become a Community Member By Clicking Here:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinOn The Pen Live Show (All Episodes In Order): https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfMFor Those Facing GLP-1 Access Issues: Https://www.FlexFinance.CareTell them “Dave sent you” 😉Zepbound FB Group:https://www.facebook.com/share/oxMJXxuLTwczPpWq/?mibextid=K35XfPSHOW LINKSNumber of people on glp-1https://www.tipranks.com/news/weight-loss-drugs-are-slimming-down-grocery-billsMorgan Stanley Sees Lilly as first 1T pharma stockhttps://www.cnbc.com/2024/02/16/zepbound-could-propel-eli-lilly-to-become-the-first-1-trillion-pharma-stock.htmlEU Kwik Pen Approvalhttps://www.reuters.com/business/healthcare-pharmaceuticals/eu-drug-regulator-review-lillys-mounjaro-multi-dose-pen-2024-02-19/Gastric Bypass and  T2Dhttps://www.medicalnewstoday.com/articles/how-gastric-bypass-surgery-can-help-with-type-2-diabetes-remissionUnfilled GLP-1 Scripts:https://www.iqvia.com/locations/united-states/blogs/2023/08/new-demand-in-an-old-marketSupport the Show.Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message.Dive deep into the Novo Nordisk and Catalent merger and how that will affect the GLP-1 market.🙏  Become a Channel Member By Clicking Here:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinOn The Pen Live Show (All Episodes In Order): https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfMFor Those Facing GLP-1 Access Issues: Https://www.FlexFinance.CareTell them “Dave sent you” 😉Zepbound FB Group:https://www.facebook.com/share/oxMJXxuLTwczPpWq/?mibextid=K35XfPThank you for watching my GLP-1 videos! If you found this content valuable, make sure to like, share, and subscribe to my channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message.Man on the Mounjaro Dave Knapp recxaps the 2023 Q4 ELi Lilly Earnings Call as it relates to obesity medicine.Link To Earnings Call: https://investor.lilly.com/webcasts-and-presentations🙏  Become a Channel Member By Clicking Here:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinOn The Pen Live Show (All Episodes In Order): https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfMFor Those Facing GLP-1 Access Issues: Https://www.FlexFinance.CareTell them “Dave sent you” 😉Zepbound FB Group:https://www.facebook.com/share/oxMJXxuLTwczPpWq/?mibextid=K35XfPThank you for watching my GLP-1 videos! If you found this content valuable, make sure to like, share, and subscribe to my channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message.🙏  Become a Channel Member By Clicking Here:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinOn The Pen Live Show (All Episodes In Order): https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfMFor Those Facing GLP-1 Access Issues: Https://www.FlexFinance.CareTell them “Dave sent you” 😉Zepbound FB Group:https://www.facebook.com/share/oxMJXxuLTwczPpWq/?mibextid=K35XfPNews Links:https://www.statnews.com/2024/02/05/amgen-obesity-drug-maintenance/https://www.marketwatch.com/story/novo-nordisks-controlling-shareholder-to-buy-catalent-for-16-5-billion-7d57fcfchttps://www.reuters.com/business/healthcare-pharmaceuticals/abbott-launches-protein-shake-brand-help-people-weight-loss-drug-2024-01-31/?fbclid=IwAR3Zo6H3oFlv64aey7pOVQ-b25HoUeFBifBmuEkIjBVyEVN9hQB-aSr9o50_aem_AUWiG99wtAtBGejL31bUvjTvF0rBp16fchnVdcRcAgUVf5uHgLByYRhedO9eJrxbHe4Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message.In this special edition of the weekly dose podcast, Dave knapp covers the recent fourth-quarter earnings call from Novo Nordisk. What does this mean for users of Ozempic Wegovy?🙏  Become a Channel Member By Clicking Here:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinOn The Pen Live Show (All Episodes In Order): https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfMPeptideVite GLP-1 Suppliment: Https://www.zennutrients.com/mounjaroman10% OFF CODE: DAVIDKZepbound FB Group:https://www.facebook.com/share/oxMJXxuLTwczPpWq/?mibextid=K35XfPFollow My Switch To Ozempic Chronologically: https://www.youtube.com/playlist?list=PLtOcNl0C8quXRPsuP6u5O5l4LuCWFHKNce#elililly #novonordisk #ozempic #wegovy #zepbound #onthepen #manonthemounjaro #semaglutide #liraglutide #saxenda #victoza #obesitymedicine #elililly #novonordisk #diabetes #diabesity #trulicityThank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!

Send us a Text Message.🙏  Become a Channel Member By Clicking Here:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinOn The Pen Live Show (All Episodes In Order): https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfMFor Those Facing GLP-1 Access Issues: Https://www.FlexFinance.CareTell them “Dave sent you” 😉Zepbound FB Group:https://www.facebook.com/share/oxMJXxuLTwczPpWq/?mibextid=K35XfPNews Links:https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Tirzepatide%20Injection&st=chttps://www.fiercebiotech.com/biotech/novo-nordisk-puts-255m-line-bag-another-obesity-asset-turning-eracal-novel-approachhttps://fortune.com/2024/01/27/north-carolina-drops-coverage-for-wegovy-and-ozempic-weight-loss-drugs/amp/https://www.reuters.com/business/healthcare-pharmaceuticals/british-regulator-clears-lillys-injection-pen-weight-loss-drug-mounjaro-2024-01-25/https://futurism.com/neoscope/study-contradicts-weight-stop-ozempic-semaglutideSupport the Show.Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!